Brittney Sabbah

@BritSab09

San Diego, startups and JLABS. Opinions are my own.

San Diego, CA
Vrijeme pridruživanja: prosinac 2016.

Tweetovi

Blokirali ste korisnika/cu @BritSab09

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BritSab09

  1. proslijedio/la je Tweet
    5. velj

    The Cool Companies is now accepting applications for their 2020 Cool Companies list! Comprising 30 of the year’s hottest venture-ready startups, connecting them with VCs from around the country to help secure funding. Apply by March 1st at

    Poništi
  2. proslijedio/la je Tweet
    3. velj

    We work to ensure the most promising healthcare innovators can focus on progressing their scientific discoveries. With more than 175 JLABS companies working on potential oncology solutions, together stand up to cancer. More:

    Poništi
  3. proslijedio/la je Tweet
    30. sij

    Could a lotion stop an outbreak in its tracks? Will a laundry detergent protect families from influenza? The seeks ideas to protect against airborne viruses that integrate seamlessly into daily life. Apply by 2/14:

    Poništi
  4. proslijedio/la je Tweet
    27. sij

    Creating potentially life changing science is hard work – but, you don’t have to do it alone! Get a feel for what it’s like to be part of the community & meet the team 1/29 👉

    Poništi
  5. proslijedio/la je Tweet
    21. sij

    Shhh! 🤫 little known fact: is best served warm (about 70 F to be exact)

    Poništi
  6. 21. sij
    Poništi
  7. 21. sij

    If you're an existing or aspiring life science entrepreneur, come have breakfast with on 1/29!

    Poništi
  8. proslijedio/la je Tweet
    11. pro 2019.

    The estimates that in 2019, 1.7 million new cancer cases were diagnosed in the U.S. Are you a nurse with an idea to potentially revolutionize oncology care? Apply for the in Oncology:

    Poništi
  9. proslijedio/la je Tweet
    9. sij

    Our leader, Sanjay Mistry shares why he loves being part of JLABS. Interested in joining our community of innovators? Meet the team on 1/29 ➡

    Poništi
  10. proslijedio/la je Tweet
    5. pro 2019.

    resident, , cleared for clinic. FDA has accepted the company’s IND application to proceed with a U.S. clinical trial of MV-012-968, an investigational vaccine for respiratory syncytial virus (RSV).

    Poništi
  11. 3. pro 2019.

    Should you hire a grant writer? ✏️ Opinions are mixed - a good strategy is to write the grant yourself (nobody knows the science better!) and have an external advisor do a mock review

    Poništi
  12. 3. pro 2019.

    many of our programs are available via Webinar and accessible from anywhere in the world? Broadcasting from now: Non-dilutive funding & how to get it 👍 – mjesto: JLABS @ San Diego

    Poništi
  13. proslijedio/la je Tweet
    3. pro 2019.

    Alumnus, , to be acquired by Astellas Pharma for $3B to accelerate the development of genetics medicines for rare neuromuscular diseases.

    Poništi
  14. 2. pro 2019.

    Don't miss out - this is TOMORROW! Spend your grant-applying time wisely – hear from experts on navigating the word of non-dilutive capital

    Poništi
  15. 27. stu 2019.

    Congrats to Alumnus, Harpoon Therapeutics, on inking a $50 million licensing deal to move their BCMA-targeting multiple myeloma candidate forward.

    Poništi
  16. proslijedio/la je Tweet
    21. stu 2019.

    Congratulations to , a recent awardee, for winning the at the 👏 Read more:

    Poništi
  17. 21. stu 2019.

    Amazing job for taking home the Catalyst Awards tonight! 🏆

    Poništi
  18. 20. stu 2019.

    Deep in conversation on at our Innovator Round Table lunch

    Poništi
  19. 19. stu 2019.

    Ahoy there! ⚓️ Sharing the JLABS Navigator online portfolio tool at our Janssen Symposium today! Check it out:

    Poništi
  20. 14. stu 2019.

    Advice for entrepreneurs getting into the space: get to know another entrepreneur who’s had success, we’re lucky in San Diego to have such a rich and collaborative community

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·